Literature DB >> 8098076

Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand.

C Y Ou1, Y Takebe, B G Weniger, C C Luo, M L Kalish, W Auwanit, S Yamazaki, H D Gayle, N L Young, G Schochetman.   

Abstract

To investigate the genetic heterogeneity and epidemiological distribution of human immunodeficiency virus type 1 (HIV-1) in Thailand, we determined proviral sequences for 63 HIV-1-infected patients in various risk groups from all over the country between April and July, 1991. Two distinct genotypes of HIV-1, A and B, were found to segregate by mode of transmission. Of 29 sexually infected patients, 25 (86%) had HIV-1 of genotype A and 4 (14%) had genotype B. Among 29 injecting drug users, probably parenterally infected, only 7 (24%) had genotype A and 22 (76%) had genotype B. This segregation is unlikely to have arisen by chance (p < 0.001). No patient was found to have dual infection. Nucleotide divergence averaged 3.4% among genotype-A-infected patients and 3.5% among genotype-B-infected patients, but 22.0% between the genotypes. 37 of 40 isolates (both genotypes) had the GPGQ tetrapeptide at the tip of the V3 loop, which is common in African HIV-1 strains but rare in North American and European strains, where the GPGR motif predominates. These findings suggest that the waves of HIV-1 infection in injecting drug users and in sexually infected patients in Thailand may not be epidemiologically linked. The nucleotide divergence data point to the separate introductions of the two genotypes in Thailand. Further studies in Thailand and neighbouring countries will be useful in the design and selection of candidate HIV vaccines.

Entities:  

Keywords:  Asia; Biology; Developing Countries; Diseases; Epidemics; Examinations And Diagnoses; Genetics; Hiv Infections--transmission; Laboratory Examinations And Diagnoses; Population At Risk; Research Methodology; Risk Factors; Southeastern Asia; Thailand; Viral Diseases

Mesh:

Substances:

Year:  1993        PMID: 8098076     DOI: 10.1016/0140-6736(93)91001-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  70 in total

1.  Characterisation of near-full length genome sequences of three South African human immunodeficiency virus type 1 subtype C isolates.

Authors:  Gillian M Hunt; Maria A Papathanasopoulos; Glenda E Gray; Caroline T Tiemessen
Journal:  Virus Genes       Date:  2003-01       Impact factor: 2.332

2.  Identification of a novel HIV type 1 circulating recombinant form (CRF52_01B) in Southeast Asia.

Authors:  Yongjian Liu; Lin Li; Zuoyi Bao; Hanping Li; Daomin Zhuang; Siyang Liu; Xiaolin Wang; Tianyi Li; Lei Jia; Shaomin Yang; Jingyun Li
Journal:  AIDS Res Hum Retroviruses       Date:  2012-04-05       Impact factor: 2.205

3.  Analysis of HIV type 1 BF recombinant sequences from South America dates the origin of CRF12_BF to a recombination event in the 1970s.

Authors:  Dario A Dilernia; Leandro R Jones; Maria A Pando; Roberto D Rabinovich; Gabriel D Damilano; Gabriela Turk; Andrea E Rubio; Sandra Pampuro; Manuel Gomez-Carrillo; Horacio Salomón
Journal:  AIDS Res Hum Retroviruses       Date:  2010-12-03       Impact factor: 2.205

4.  Langerhans cell tropism of human immunodeficiency virus type 1 subtype A through F isolates derived from different transmission groups.

Authors:  M T Dittmar; G Simmons; S Hibbitts; M O'Hare; S Louisirirotchanakul; S Beddows; J Weber; P R Clapham; R A Weiss
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

5.  Exploration of antigenic variation in gp120 from clades A through F of human immunodeficiency virus type 1 by using monoclonal antibodies.

Authors:  J P Moore; F E McCutchan; S W Poon; J Mascola; J Liu; Y Cao; D D Ho
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

6.  A human monoclonal antibody to a complex epitope in the V3 region of gp120 of human immunodeficiency virus type 1 has broad reactivity within and outside clade B.

Authors:  J P Moore; A Trkola; B Korber; L J Boots; J A Kessler; F E McCutchan; J Mascola; D D Ho; J Robinson; A J Conley
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

7.  Molecular epidemiology of HIV type 1 in Singapore and identification of novel CRF01_AE/B recombinant forms.

Authors:  Oon Tek Ng; Supriya Munshaw; Susanna L Lamers; Kuan Kiat Chew; Li Lin; Andrew D Redd; Jordyn Manucci; Thomas C Quinn; Stuart C Ray; Arlene Chua; Yee Sin Leo; Oliver Laeyendecker
Journal:  AIDS Res Hum Retroviruses       Date:  2011-02-14       Impact factor: 2.205

8.  Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG.

Authors:  A Trkola; A B Pomales; H Yuan; B Korber; P J Maddon; G P Allaway; H Katinger; C F Barbas; D R Burton; D D Ho
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  A naturally occurring single basic amino acid substitution in the V3 region of the human immunodeficiency virus type 1 env protein alters the cellular host range and antigenic structure of the virus.

Authors:  T Shioda; S Oka; S Ida; K Nokihara; H Toriyoshi; S Mori; Y Takebe; S Kimura; K Shimada; Y Nagai
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

10.  A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1.

Authors:  F Gao; D L Robertson; C D Carruthers; S G Morrison; B Jian; Y Chen; F Barré-Sinoussi; M Girard; A Srinivasan; A G Abimiku; G M Shaw; P M Sharp; B H Hahn
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.